Shanghai Universal Biotech Co.,Ltd. (SHE:301166)

SHE:301166 Revenue

Shanghai Universal Biotech had revenue of 309.23M CNY in the quarter ending June 30, 2026, with 7.20% growth. This brings the company's revenue in the last twelve months to 1.15B, up 7.23% year-over-year. In the year 2025, Shanghai Universal Biotech had annual revenue of 1.08B, down -3.05%.

• Revenue (ttm): 1.15B
• Revenue Growth: +7.23%
• P/S Ratio: 2.18
• Revenue / Employee: 1.42M
• Employees: 810
• Market Cap: 2.51B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.08B	-34.05M	-3.05%
Dec 31, 2024	1.12B	-108.07M	-8.82%
Dec 31, 2023	1.23B	30.70M	2.57%
Jan 1, 2023	1.20B	85.46M	7.70%
Jan 1, 2022	1.11B	260.59M	30.69%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error